Daymark Wealth Partners LLC Has $1.28 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Daymark Wealth Partners LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 31.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,703 shares of the company's stock after buying an additional 890 shares during the period. Daymark Wealth Partners LLC's holdings in HCA Healthcare were worth $1,280,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $1,021,000. Kestra Private Wealth Services LLC lifted its stake in shares of HCA Healthcare by 15.4% in the fourth quarter. Kestra Private Wealth Services LLC now owns 2,288 shares of the company's stock valued at $687,000 after buying an additional 305 shares during the period. Activest Wealth Management boosted its holdings in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Angeles Wealth Management LLC increased its stake in shares of HCA Healthcare by 7.0% in the fourth quarter. Angeles Wealth Management LLC now owns 808 shares of the company's stock valued at $243,000 after buying an additional 53 shares in the last quarter. Finally, Savant Capital LLC boosted its position in HCA Healthcare by 4.1% in the 4th quarter. Savant Capital LLC now owns 3,673 shares of the company's stock valued at $1,102,000 after buying an additional 146 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of research analyst reports. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and lifted their target price for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Royal Bank of Canada reduced their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Morgan Stanley boosted their price target on HCA Healthcare from $355.00 to $410.00 and gave the company an "equal weight" rating in a research note on Monday. Finally, Barclays set a $416.00 target price on HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $392.47.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

HCA Healthcare stock traded down $8.22 during midday trading on Tuesday, reaching $364.79. The company's stock had a trading volume of 1,914,949 shares, compared to its average volume of 1,446,989. The business has a 50-day moving average price of $355.79 and a 200-day moving average price of $332.05. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $87.76 billion, a PE ratio of 16.60, a price-to-earnings-growth ratio of 1.10 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company's revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.36 earnings per share. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.79%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.